Memopezil is at the center of a rapidly growing conversation about cognitive health in 2026, as consumer interest in brain support has reached an all-time high, with search volume for terms like ...

The impact of neflamapimod on neurofilament light levels will be examined in a study of approximately 35 patients with ALS, facilitated by the EXPERTS-ALS platform, according to a press release from ...

The selective muscarinic agonist is now in mid-stage development for movement disorders like Parkinson’s disease and dystonia ...

Bioavailability data recently obtained from Phase 1 study with a stable crystal form of neflamapimod manufactured using a new ...

According to Dr. Alanna Stetson, president of PEI Association of Optometrists, while prolonged use of digital devices can cause temporary discomfort and eyestrain, it will not lead to permanent damage ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for isolated dystonia and for Parkinson’s diseaseFirst ...

Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...

Vagus nerve stimulation may treat many diseases by changing brain signals, inflammation, and organ communication.

It’s worth knowing whether you’re just playing a game you like — or maybe also improving your brain chemistry.

People who use drugs with anticholinergic effects, including certain antidepressants, drugs for urinary incontinence and ...